Home/Filings/4/0001209191-23-019723
4//SEC Filing

Kornitzer Benjamin 4

Accession 0001209191-23-019723

CIK 0001831097other

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 4:55 PM ET

Size

9.2 KB

Accession

0001209191-23-019723

Insider Transaction Report

Form 4
Period: 2023-03-15
Kornitzer Benjamin
Chief Med. & Quality Officer
Transactions
  • Sale

    Common Stock

    2023-03-15$23.81/sh55,000$1,309,42455,426 total
  • Exercise/Conversion

    Common Stock

    2023-03-15$4.49/sh+100,000$449,000110,426 total
  • Exercise/Conversion

    Options (Rights to Buy)

    2023-03-15100,000175,000 total
    Exercise: $4.49Exp: 2030-01-31Common Stock (100,000 underlying)
Footnotes (3)
  • [F1]Includes restricted stock units.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.465 to $24.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F3]These options were granted on January 31, 2020 and vest in four equal installments on January 31 of each of 2021, 2022, 2023, and 2024.

Issuer

agilon health, inc.

CIK 0001831097

Entity typeother

Related Parties

1
  • filerCIK 0001855842

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:55 PM ET
Size
9.2 KB